Jefferies Financial Group Inc. Takes $2.18 Million Position in Plexus Corp. $PLXS

Jefferies Financial Group Inc. acquired a new stake in Plexus Corp. (NASDAQ:PLXSFree Report) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 14,843 shares of the technology company’s stock, valued at approximately $2,182,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in PLXS. American Century Companies Inc. grew its position in shares of Plexus by 44.2% in the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after purchasing an additional 338,119 shares during the period. Balyasny Asset Management L.P. purchased a new stake in shares of Plexus in the third quarter valued at $12,509,000. Arrowstreet Capital Limited Partnership grew its position in shares of Plexus by 965.0% in the third quarter. Arrowstreet Capital Limited Partnership now owns 80,890 shares of the technology company’s stock valued at $11,704,000 after purchasing an additional 73,295 shares during the period. Qube Research & Technologies Ltd grew its position in shares of Plexus by 37.1% in the second quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock valued at $32,843,000 after purchasing an additional 65,644 shares during the period. Finally, Bank of America Corp DE grew its position in shares of Plexus by 53.6% in the second quarter. Bank of America Corp DE now owns 177,237 shares of the technology company’s stock valued at $23,982,000 after purchasing an additional 61,817 shares during the period. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Wall Street Analyst Weigh In

PLXS has been the subject of a number of recent analyst reports. Stifel Nicolaus set a $280.00 price objective on Plexus in a research report on Tuesday. Weiss Ratings raised Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Benchmark reissued a “buy” rating and set a $220.00 price target on shares of Plexus in a research report on Monday, March 16th. Williams Trading set a $195.00 price target on Plexus in a research report on Wednesday, January 28th. Finally, Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Plexus presently has a consensus rating of “Moderate Buy” and a consensus price target of $234.17.

View Our Latest Stock Report on Plexus

Insider Transactions at Plexus

In other Plexus news, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $264.75, for a total transaction of $865,732.50. Following the transaction, the executive vice president owned 16,266 shares in the company, valued at $4,306,423.50. The trade was a 16.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Karen Marie Rapp sold 500 shares of the business’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $195.59, for a total value of $97,795.00. Following the transaction, the director owned 8,535 shares in the company, valued at approximately $1,669,360.65. This represents a 5.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 19,971 shares of company stock worth $5,098,446 in the last three months. 1.78% of the stock is currently owned by insiders.

Plexus Price Performance

PLXS stock opened at $272.91 on Wednesday. The stock has a 50-day moving average price of $233.42 and a two-hundred day moving average price of $192.27. Plexus Corp. has a 12-month low of $115.35 and a 12-month high of $275.83. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The company has a market cap of $7.30 billion, a PE ratio of 39.90 and a beta of 0.88.

Plexus (NASDAQ:PLXSGet Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same quarter in the previous year, the business earned $1.66 earnings per share. The firm’s quarterly revenue was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, research analysts predict that Plexus Corp. will post 5.98 EPS for the current year.

About Plexus

(Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Read More

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.